The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced new data from the randomized, ...

Aspirin reduced disease recurrence in patients PI3K-mutated colorectal cancer, underscoring the value of early genomic ...

Surufatinib plus TAS-102 showed promising survival benefits with manageable toxicity in refractory metastatic PDAC patients, ...

Cancellations of NIH grant review panels, in particular, could affectcancer research grants and funding. In these NIH grant ...

Three-fourths of patients with unresectable gastroesophageal cancer converted to resectable and had clear margins after ...

Oncology practices at Olean General Hospital's Barry Street Health Center and at Bradford Regional Medical Center have received recertification by the Association for Clinical Oncology, an affiliate o ...

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, ...

Afinitor plus Somatuline showed an improved survival compared with Afinitor monotherapy in patients with gastroenteropancreatic neuroendocrine tumors.